Which statement accurately describes payment to research subjects for participating in clinical trials? Question 11 options: Payment is considered a benefit that contributes to the weighing of risks and benefits. Payment serves as compensation for time and inconvenience, but it is not part of the risk-benefit assessment. Payment must be made contingent upon completing the entire study. Payment is primarily intended to encourage subjects to provide informed consent. Payment for participating in a study is never appropriate